Header Logo

Connection

JOHN KIRKWOOD to Vincristine

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Vincristine.
JOHN KIRKWOOD
Connection Strength
0.015
Vincristine
  1. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2008 Dec 10; 26(35):5748-54.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.